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Efficacy of Cytology for the Diagnosis of Chlamydia trachomatis in Pregnant Women
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This study evaluated the effectiveness of Papanicolaou staining for the initial diagnosis of
Chlamydial infection in pregnant women. A hundred thirteen patients were examined with a
Papanicolaou test, independent of gestational age, parity or maternal age. Three endocervical
samples were collected; the first two were collected with a brush (Cytobrush plus, Mediscand,
Sweden) and the third with Ayre’s spatula. The first specimen was used for McCoy cell culture and
the other two were examined cytologically.  Chlamydial infection was detected in 9 (7.9%) patients.
Only one (0.8%) was diagnosed by cytological exam. The sensitivity and specificity of the cytological
examination were 10 and 98%, respectively. The estimated positive predictive value was 33.3% and
the negative predictive value was 92.7%. When Papanicolaou stain diagnosis suggests Chlamydia,
a more specific complementary exam should be added to confirm infection; subsequently adequate
treatment can be implemented, thereby preventing the frequent complications of untreated
subclinical infections.
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Chlamydia trachomatis, an obligate intracellular
pathogen, has been considered a bacterium since 1964. There
are three biotypes: a rat pneumonia agent, a venereal disease
agent and an eye-genital disease agent [1]. This species
obtains its energy from host cells, and it preferentially infects
the genital epithelia and the eyes [2]. This agent is responsible
for more than three million cases of infection per year in the
United States [3]. Chlamydial infection can be asymptomatic
in women, as well as in men and newborns. In women, recurrent
discharges, urethritis and cervicitis, pelvic inflammatory
illness, ectopic pregnancy, infertility and chronic pelvic pain,
suggest C. trachomatis infection [4,5]. An association between
genital infection with Chlamydia and cervical intraepithelial
neoplasia and cervix carcinoma has been reported [6]. This
agent also increases the risk of infection by the human
immunodeficiency virus [7]. In men, it can cause non-
gonococcic urethritis, acute epididymitis, infertility, chronic
prostatitis and other complications [8]. In pregnant women,
C. trachomatis infection can affect pregnancy outcome,
causing preterm labor, puerperal endometritis, low-weight in
the newborn, as well as conjunctivitis and neonatal pneumonia
[9-11]. New diagnostic methods have appeared in recent years;
however, these are still inaccessible for most of the population.
The available laboratorial tests for the detection of Chlamydia
include McCoy cell culture, direct immunofluorescence,
enzymatic immunoassay, hybrid capture, and polymerase
chain reaction (PCR); the latter gives the greatest sensitivity.
Indirect diagnosis tests, such as a search for specific
antibodies and Papanicolaou staining, though they have low
sensitivity, are often the only available examination for many
women [12,13]. The culture technique, which is a diagnostic
method with high sensitivity and specificity (80% and 100%,
respectively), is costly, time consuming, and requires
considerable expertise, which limits its use in large healthcare
centers [12]. The Papanicolaou stain, well established for the
detection of pre-cancer cervix lesions, has been used as
alternative method for the diagnosis of the C. trachomatis
[14]. Considering that the Papanicolaou stain is routinely used
in all the medical assistance services that attend woman, we
evaluated its effectiveness for the initial diagnosis of
Chlamydia infection in pregnant women.
Ethical aspects
The voluntary agreement of the patients was assured, as
they signed an informed consent term. This research was
approved by the Ethics Committee for research of the Federal
University of São Paulo - UNIFESP. The authors affirm the
inexistence of a conflict of interest (professional, financial
and indirect or direct benefits) that could influence the results
of the research.
Material and Methods
We studied 113 pregnant women in prenatal care at
UNIFESP from October 1992 to September 1994. The patients
were examined with a Papanicolaou test, whenever they had
not been tested previously, independent of gestational age,
parity and maternal age. Exclusion criteria were: obstetrics
complications that could be aggravated by cervical
manipulation or antibiotic use during the four preceding weeks.
Three endocervical samples were collected; the first two with
a brush (Cytobrush plus, Mediscand, Sweden) and the third
with Ayre’s spatula. The first specimen was used for culture
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and the other two were examined cytologically. The
specimens for McCoy cell culture were placed in test tubes
containing glass pearls and were kept under refrigeration,
while they were transported to the Adolph Lutz Institute
Chlamydia and Rickettsiae Laboratory. They were prepared
in petri dishes containing 2SP1 solution. The samples were
then inoculated, in duplicate, into cell culture bottles
containing prepared McCoy cells.
The culture bottles were centrifuged at 2500 x g at 30°C
for one hour. After centrifugation, the inoculates were
removed and 1ml of half minimum modified Eagle medium
supplemented with cycloheximide (2μg/mL) was added. The
identification of Chlamydia was made using an indirect
immunofluorescence reaction (IFR). The antibody was
human serum for LV (Lymphogranuloma venereum); human
serum anti-IgG conjugated with fluorescein was used to
reveal the reaction. The reaction was made in only one of
the culture bottles; the other was used to process
successive passage into new cell culture bottles. The
cultures that were considered positive presented one or
more typical inclusions, when the fluorescence intensity
in the plates was two plusses (+ +) or more, on a scale of 0
to 4 plusses. The cultures were considered negative if no
inclusion was found after the second passage. The
Papanicolaou test was made on two previously identified
samples; one had the endocervical specimens collected
with the cytobrush and second was the specimen obtained
with Ayre’s spatula from the vagina and ectocervix,
including the transformation zone. After fixing in 95%
ethanol, the samples were stained with the Papanicolaou
technique. The diagnosis of C. trachomatis infection was
based on Gupta’s alterations [15], which include the finding
of coccoid inclusion bodies in the vacuoles, in the
perinuclear region or in the cytoplasm in a dense
acidophilus aggregate, as well as irregular edge inclusions,
encircled by a clear zone, presenting central condensation.
The effectiveness of the cytological examination for C.
trachomatis diagnosis was determined through the
calculation of sensitivity, specificity, negative predictive
values and false-negative probabilities.
Results
We detected endocervical and/or metaplasic cells in 31
samples (27.4%) collected by Ayre’s spatula, while all the
specimens obtained with the cytobrush showed these cellular
types (Table 1). Cell culture was considered the gold standard
diagnosis. Chlamydial infection was detected in 9 (7.9%)
patients. Only one (0.8%) was diagnosed by cytological exam.
The remaining 104 (92.1%) women did not have a positive
culture for Chlamydia. The cytology presented similar negative
values for 102 patients (90.3%) (Table 2). The sensitivity and
specificity of the cytological examination were 10% and 98%,
respectively. The estimated positive predictive value was
33.3% and the negative predictive value was 92.7%.
Discussion
Diagnosis of C. trachomatis infection is still critical, due
to the high frequency of nonsymptomatic infections and the
necessity of complementary exams. Screening tests for
Chlamydia infection have reduced pelvic inflammatory disease
incidence by 56% [16], confirming their importance in reducing
morbidity due to Chlamydia infection in the genital tract. We
Table 1. Endocervical and/or metaplasical cell frequency in samples taken with Ayre’s spatula and a cytobrush
Table 2. Cytology and culture results for Chlamydia trachomatis in pregnant women
Chlamydia trachomatis in Pregnant Women
Spatula Spatula + cytobrush
N (%) N (%)
Positive 31 (27.4) 113 (100)
Negative 82 (72.6) 0 (0)




Cytology Positive Negative Total
N (%) N (%) N (%)
Positive 1 (0.8) 2 (1.8) 3 (2.6)
Negative 8 (7.1) 102 (90.3) 110 (97.4)
Total 9 (7.9) 104 (92.1) 113 (100)
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used cell culture as a gold standard for Chlamydia infection.
Advantages of cell culture include low probability of
contamination and preservation of the microorganisms for
future study [12]. The main disadvantage is the necessity of
an expensive laboratorial infrastructure; it is also laborious
and demands careful handling to maintain the
microorganisms viable. However, this is compensated by
100% specificity and 80% sensitivity [12]. In our study the
prevalence of Chlamydia infection among the pregnant
women, determined by cell culture, was 8.0%, similar to
literature values [7,17,18]. Some authors [18,19] have
suggested that the cytological method can be used for
screening of this infection, with the intention to use more
specific tests later. The Papanicolaou stain is widely used in
all medical assistance units that attend woman; that is why
we evaluated the effectiveness of this cytological test for
screening Chlamydial infection during pregnancy. To ensure
that metaplasic and/or endocervical cells were available for
cytological evaluation, the material was collected with a soft-
bristle brush as well as with the traditional Ayre’s spatula;
this was done to avoid endocervical traumas. Due to the use
of these brushes, endocervical and/or metaplasic cells were
found in all samples, demonstrating the importance of using
adequate tools for specimen collection, especially when
looking for Chlamydia infection, which is preferentially found
in endocervical cells (Table 1). This collection technique
improved the vaginal samples, although it did not improve
the sensitivity of the Papanicolaou test for Chlamydia
infection diagnosis, as the prevalence indirectly diagnosed
by Gupta’s criteria was only 2.6% [15]. We found
endocervical cells in 100% of the samples, while other studies
[19,20] reported a lower percentage (64%) of satisfactory
samples (with endocervical cells). The scarcity of
endocervical cells in pregnant women samples could be
explained by the extreme care of clinicians when
manipulating the endocervical canal during collection.
However, in ours and in other studies [21], “cytobrush” use
did not induce any complications during gestation.
Using only Gupta’s criteria [15] for the presumptive
diagnosis of Chlamydia infection excludes the “search
signals”, which consist of eosinophilia, amphophilia,
cytoplasm vacuolization and perinuclear halos [20]. These
are also inherent to Chlamydia infection, which could have
been present in some infected patients who were not identified.
Other factors could also justify the low sensitivity of cytology
that we observed in our study (10%), compared to other
studies (62%) [13]; these include few infected cells in the
samples and rupture of the inclusions at the time the samples
were prepared [21, 22].
Conclusions
Considering that cytological exams are routinely made
of women in all medical assistance services for, it would be
useful to include a collection procedure directed towards
the identification of Chlamydia infection, based on the high
cytology specificity observed in our study (98%). When
Papanicolaou stain diagnosis suggests Chlamydia, a more
specific complementary exam should be added to confirm
infection, so that adequate treatment can be implemented,
avoiding the complications of untreated subclinical
infections.
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